Sudo Biosciences
Highly Engaged Employees
Manufacturing · Indiana, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10401 N Meridian St Ste 225, Carmel, Ind...Phone Number
(317) 564-8990Website
www.sudobio.comRevenue
<$5 MillionIndustry
About Sudo Biosciences
Sudo Biosciences Org Chart
Is Sudo Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Sudo Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Sudo Biosciences
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Sudo Biosciences recently announced quarterly report
Product Launch: Get notified when Sudo Biosciences launches new products
Funding: Get notified immidiatlly once Sudo Biosciences has new funding data
Check if Sudo Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Sudo Biosciences had a recent Job posting/layoffs
Check out if Sudo Biosciences is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Sudo Biosciences as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Sudo Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sudo Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sudo Biosciences.
Sudo Biosciences financials insights
Gather financial insights about Sudo Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$37M
Series B
$147M
Sudo Biosciences Tech Stack
A closer look at the technologies used by Sudo Biosciences
Most Recent Scoops
Sudo Biosciences News & Media
Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550
CARMEL, Ind.--(BUSINESS WIRE)-- #TYK2--Sudo Biosciences Announces First Participants Dosed in Phase 1 Trial of Brain-Penetrant Allosteric TYK2 Inhibitor SUDO-550Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M
CARMEL, Ind.--(BUSINESS WIRE)-- #TYK2--Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147MSudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the Clinic
CARMEL, Ind.--(BUSINESS WIRE)-- #TYK2--Sudo Biosciences Raises $116M Series B Financing to Advance Potential Best-in-Class TYK2 Therapeutics Programs into the ClinicSudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer
MENLO PARK, Calif.--(BUSINESS WIRE)-- #ChiefBusinessOfficer--Sudo Biosciences Appoints Imran Babar, Ph.D., as Chief Business Officer
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sudo Biosciences
Founded in 2020 and headquartered in Menlo Park, California, Sudo Biosciences is a biopharmaceutical company.... Read More